GlaxoSmithKline PLCAdd to My Watchlist

GSK:USNew YorkIndustry: Medical-Drugs
  • 40.16
  • 0.44  1.11%
    Today's Change
  • 39.72
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 10/8/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding2 billion
Market Cap$98 billion
Return on Equity ttm149.51%
Last Dividend$0.57
Dividend Yield ttm6.15
Relative Dividend Yield benchmark--
Dividend Ex-Date8/12/15
Dividend Pay Date10/1/15
EPS: Year Actual ttm--
EPS: Year Est. 12/15 ttm1.528
EPS: Quarterly Actual 6/15 --
EPS: Quarterly Est. 9/15 0.39
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-49.07
Company Description
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
Revenue$23 billion
Net Income$3 billion
Total Assets$41 billion

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!